Alexander Nowak
Stock Analyst at Craig-Hallum
(2.74)
# 2,104
Out of 5,090 analysts
46
Total ratings
45.95%
Success rate
7.33%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $105.63 | +2.24% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $9.05 | +143.09% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $244.55 | -35.80% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.09 | +139.77% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.76 | +105.33% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $18.53 | -19.05% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $8.78 | -8.88% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.01 | +795.52% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $20.92 | +139.01% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $11.84 | +1,251.35% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $101.06 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.71 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.41 | +356.43% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $61.68 | +78.34% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.62 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.07 | +14,392.75% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $8.89 | +214.96% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $105.63
Upside: +2.24%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $9.05
Upside: +143.09%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $244.55
Upside: -35.80%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.09
Upside: +139.77%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.76
Upside: +105.33%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $18.53
Upside: -19.05%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $8.78
Upside: -8.88%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.01
Upside: +795.52%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $20.92
Upside: +139.01%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $11.84
Upside: +1,251.35%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $101.06
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.71
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.41
Upside: +356.43%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $61.68
Upside: +78.34%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.62
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.07
Upside: +14,392.75%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $8.89
Upside: +214.96%